Picture of IRIDEX logo

IRIX — IRIDEX News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Iridex Corp Reports Results For The Quarter Ended In September: Earnings Summary

* IRIDEX Corp  IRIX.OQ  reported a quarterly adjusted loss
of 11
cents​​ per share for the quarter ended in September. The mean
expectation of two analysts for the quarter was for a loss of 14
cents per share.
    * Revenue rose 10.3% to $14.64 million from a year ago;
analysts
expected $13.87 million. 
    * IRIDEX Corp's reported EPS for the quarter was a loss
of 11
cents​.
    * The mean earnings estimate of analysts had fallen by
about 11.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * IRIDEX Corp shares had fallen by 17.0% this quarter and
lost 67.3% so far this year.
    * The company reported a quarterly loss of $1.77 million.
    * Wall Street's median 12-month price target for IRIDEX Corp
is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:41 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.14          -0.11          Beat
 Jun. 30 2022      -0.15          -0.14          Beat
 Mar. 31 2022      -0.16          -0.15          Beat
 Dec. 31 2021      -0.11          -0.15          Missed

Recent news on IRIDEX

See all news